[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
Centre Eugène-Marquis, Rennes
Patrick
P
Bourguet
D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging; D004067:Digestive System Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy; D004938:Esophageal Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging; D019275:Radiopharmaceuticals; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy; D014055:Tomography, Emission-Computed / Q000379:methods / Q000592:standards*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18